<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>4474526 Figure_1-B</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot analysis of Shp2 in control and Shp2 ko cells.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_1-C-D</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 1-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>Immunofluorescence analysis of Ki67 on control and Shp2 ko cells at day 7. Scale bar, 50 &#956;m. Quantification of the numbers of Ki67+cells shown in (C). Error bars represent SEM (n = 3). **P 0.01.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_1-E-F</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 1-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>phere formation by control and Shp2 ko cells at day 7. Scale bar, 200 &#956;m. Quantification of the numbers of spheres formed by control and Shp2 ko cells shown in (E). Error bars represent SEM (n = 3). **P 0.01.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_1-G</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 1-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G</infon>
    <passage>
      <offset>0</offset>
      <text>Growth kinetics of spheres formed by control and Shp2 ko cells by counting sphere cells at day 4, 7, and 12. Error bars represent SEM (n = 3).</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_1-H-I</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 1-H-I</infon>
    <infon key="sourcedata_figure_dir">Figure_1-H-I</infon>
    <passage>
      <offset>0</offset>
      <text>SA&#8208;&#946;&#8208;gal staining on spheres formed by control and Shp2 ko cells at day 7. Scale bar, 100 &#956;m. Quantification of the numbers of senescent cells in the spheres shown in (H). Error bars represent SEM (n = 3). **P 0.01.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_1-J</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 1-J</infon>
    <infon key="sourcedata_figure_dir">Figure_1-J</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot analysis of H3K9me3, p27, p53 pS18 (Ser18&#8208;phosphorylated p53), total p53, Shp2, and &#945;&#8208;tubulin in control and Shp2 ko cells.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_1-K-L-M</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 1-K-L-M</infon>
    <infon key="sourcedata_figure_dir">Figure_1-K-L-M</infon>
    <passage>
      <offset>0</offset>
      <text>SA&#8208;&#946;&#8208;gal staining on spheres formed by control cells and those treated by the Shp2 inhibitor GS493 at 15 &#956;M at day 7. Scale bar, 100 &#956;m. Quantification of the numbers of senescent cells shown in (K). Error bars represent SEM (n = 3). **P 0.01. Quantification of the numbers of spheres formed by control cells and those treated by the Shp2 inhibitor GS493 at 15 &#956;M. Error bars represent SEM (n = 3). **P 0.01. Statistical significance was assessed by Student's unpaired t&#8208;test.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_2-B</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>qRT-PCR analysis of mRNA levels of Skp2, Aurka, Dll1, and Hey1 in control, Shp2 ko, and Shp2&#8208;inhibited cells. Error bars represent SEM (n = 3).</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_2-C-D-E</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 2-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>SA&#8208;&#946;&#8208;gal staining on control, Shp2 ko, and Shp2 ko cells with overexpression of Skp2, Aurka, or N3IC cDNA. Scale bar, 100 &#956;m. Quantification of the numbers of senescent cells shown in (C). Error bars represent SEM (n = 3). **P 0.01; ***P 0.001. Quantification of the numbers of spheres formed by cells shown in (C). Error bars represent SEM (n = 3). *P 0.05; **P 0.01; and ***P 0.001. Statistical significance was assessed by Student's unpaired t&#8208;test.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_3-A-B-C</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 3-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>SA&#8208;&#946;&#8208;gal staining on control, Shp2 ko, and Shp2 ko cells with shRNA knockdown of p27 or p53. Scale bar, 50 &#956;m. Quantification of the numbers of senescent cells shown in (A). Error bars represent SEM (n = 3). **P 0.01. Quantification of the numbers of spheres formed by cells shown in (A). Error bars represent SEM (n = 3). **P 0.01.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_3-D</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot analysis of p27, p53, and &#945;&#8208;tubulin in control, Shp2 ko, and Shp2 ko cells with overexpression of Skp2, Aurka, or N3IC cDNAs. The numbers below indicate the relative ratios of band intensities between p27 and &#945;&#8208;tubulin or between p53 and &#945;&#8208;tubulin.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_3-E</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot analysis of p27, p53, and &#945;&#8208;tubulin in PyMT cells treated with control (DMSO) or inhibitors against Skp2 (MLN4924), Aurora A (VX&#8208;680), or Notch (DAPT) at the indicated concentrations. The numbers below indicate the relative ratios of band intensities between p27 and &#945;&#8208;tubulin or between p53 and &#945;&#8208;tubulin.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_3-F</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>Quantification of the numbers of senescent cells in PyMT cells treated with control, MLN4924, MLN4924 plus p27 knockdown or MLN4924 plus p53 knockdown. Error bars represent SEM (n = 3). **P 0.01; NS, not significant.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_3-G</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 3-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G</infon>
    <passage>
      <offset>0</offset>
      <text>Quantification of the numbers of senescent cells in PyMT cells treated with control, VX&#8208;680, VX&#8208;680 plus p27 knockdown, or VX&#8208;680 plus p53 knockdown. Error bars represent SEM (n = 3). *P 0.05; NS, not significant.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_3-H</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 3-H</infon>
    <infon key="sourcedata_figure_dir">Figure_3-H</infon>
    <passage>
      <offset>0</offset>
      <text>Quantification of the numbers of senescent cells in PyMT cells treated with control, DAPT, DAPT plus p27 knockdown, or DAPT plus p53 knockdown. Error bars represent SEM (n = 3). **P 0.01; NS, not significant. Statistical significance was assessed by Student's unpaired t&#8208;test.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_4-A</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>SA&#8208;&#946;&#8208;gal staining on MLN4924 tumorcells treated with control, Shp2 inhibitor GS493 (15 &#956;M), Src inhibitor PP2 (2.5 &#956;M), Fak inhibitor TAE226 (0.5 &#956;M), or Mek1 inhibitor U0126 (20 &#956;M). Scale bar, 100 &#956;m.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_4-B-C</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 4-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>Quantification of the numbers of senescent cells in the presence or absence of the inhibitors, as shown in (A). Error bars represent SEM (n = 3). *P 0.05; **P 0.01. Quantification of the numbers of spheres in the presence or absence of the inhibitors, as in (A). Error bars represent SEM (n = 3). *P 0.05; **P 0.01</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_4-D</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot analysis of pY527, pY416 and total Src, pY925 and total Fak, pT202/pT204 and total Erk1/2, and &#945;&#8208;tubulin in MLN4924 tumorcells with or without treatment with 5 &#956;M GS493.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_4-E</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>qRT-PCR analysis of mRNA levels of Skp2, Aurka, Dll1, and Hey1 in control cells and those treated with the indicated inhibitors. Error bars represent SEM (n = 3).</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_5-A</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Kaplan-Meier survival analysis of humanpatients (n = 3,935) with invasive breast cancers divided into two groups based on the gene expression level of Shp2 (see ).</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_5-B-C</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 5-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B-D Kaplan-Meier survival analyses of the humanpatients (n = 3,935) divided into two groups based on the expression level of the genes of each overrepresented class determined in Fig A: cell cycle genes, DNA replication genes, or p53 target genes.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_5-D</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>B-D Kaplan-Meier survival analyses of the humanpatients (n = 3,935) divided into two groups based on the expression level of the genes of each overrepresented class determined in Fig A: cell cycle genes, DNA replication genes, or p53 target genes.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_5-E-F</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 5-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E, F Kaplan-Meier survival analyses of humanpatients (n = 3,935) divided into two groups based on the gene expression level of Skp2 or Aurka. HR, hazard ratio.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_6-A</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>Kaplan-Meier analyses of tumor formation for control (MLN4924;Shp2fl/fl, blue, n = 33), heterozygous Shp2 mutant (MLN4924;MMTV&#8208;Cre;Shp2+/fl, green, n = 15), and homozygous Shp2 mutant (MLN4924;MMTV&#8208;Cre;Shp2fl/fl, also called MLN4924;coShp2, orange, n = 34) mice. ***P 0.001 (log&#8208;rank test).</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_6-B-C</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 6-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>Mammary gland whole&#8208;mounts from control MLN4924 and MLN4924;MMTV&#8208;Cre;Shp2fl/flmice at indicated ages. The characteristic lymph node of the mammary glandfat pad is marked by white arrowheads; premalignant lesions are marked by red arrowheads. Scale bar, 4 mm. Quantification of premalignant lesions in mammary glands of control MLN4924 and MLN4924;MMTV&#8208;Cre;Shp2fl/flmice, as shown in (B). Error bars represent SEM (n = 6). *P 0.05 (Student's unpaired t&#8208;test).</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_7-A</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>Immunostaining of EYFP and CK8 on mammary gland sections from MLN4924;MMTV&#8208;Cre;Shp2+/fl;EYFP&#8722;/fl and MLN4924;MMTV&#8208;Cre;Shp2fl/fl;EYFP&#8722;/flmice at hyperplasia, adenoma, and carcinoma stages. Scale bar, 100 &#956;m. n = 8.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_7-B</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>Immunohistochemistry analysis of Cre recombinase on paraffin sections of primary tumors (top) and metastases (bottom) from MLN4924;Shp2fl/fl, MLN4924;MMTV&#8208;Cre;Shp2+/fl, and MLN4924;MMTV&#8208;Cre;Shp2fl/flmice. Scale bar, 100 &#956;m. n = 8.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_7-C</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>qRT-PCR analyses of Shp2mRNA levels in tumor tissues from MLN4924;Shp2fl/fl (n = 8), MLN4924;MMTV&#8208;Cre;Shp2+/fl (n = 6), and MLN4924;MMTV&#8208;Cre;Shp2fl/fl (n = 6) mice. Error bars represent upper and lower quartiles.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_7-D</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot analysis of Shp2protein levels in tumor tissues from MLN4924;Shp2fl/fl, MLN4924;MMTV&#8208;Cre;Shp2+/fl, and MLN4924;MMTV&#8208;Cre;Shp2fl/flmice.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_8-A</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>Immunohistochemistry analysis of EYFP (top) and SA&#8208;&#946;&#8208;gal staining (bottom) on cryosections of mammary glandtumors from control MLN4924;Shp2fl/fl;EYFP&#8722;/fl, MLN4924;MMTV&#8208;Cre;Shp2+/fl;EYFP&#8722;/fl, and MLN4924;MMTV&#8208;Cre;Shp2fl/fl;EYFP&#8722;/flmice. Note that SA&#8208;&#946;&#8208;gal activity was present in the EYFP&#8208;positive (Shp2&#8208;negative) areas (right, arrows) and was absent in the EYFP&#8208;negative (Shp2&#8208;positive) areas (right, arrowhead) of mammary glandtumors of MLN4924;MMTV&#8208;Cre;Shp2fl/fl;EYFP&#8722;/flmice. Consecutive sections of EYFP and SA&#8208;&#946;&#8208;gal staining for each group are shown. Scale bar: 100 &#956;m. n = 5.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_8-B</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>Immunofluorescence analysis of Ki67, EYFP and CK8 (pan&#8208;epithelial marker) (top panel), p27 and EYFP (middle panel), and p53 and EYFP (bottom panel) on cryosections of mammary glandtumors from control MLN4924;Shp2fl/fl;EYFP&#8722;/fl, MLN4924;MMTV&#8208;Cre;Shp2+/fl;EYFP&#8722;/fl, and MLN4924;MMTV&#8208;Cre;Shp2fl/fl;EYFP&#8722;/flmice. DAPI was used for nuclear counterstain. Ki67 was absent in EYFP&#8208;positive cells (top right, arrows) and was present in EYFP&#8208;negative cells (top right, arrowheads); p27 was present in EYFP&#8208;positive cells (middle right, arrows) and was absent in EYFP&#8208;negative cells (middle right, arrowhead); and p53 was present in EYFP&#8208;positive cells (bottom right, arrows) and was absent in EYFP&#8208;negative cells (bottom right, arrowhead). Scale bar: top panel, 100 &#956;m; middle and bottom panel, 50 &#956;m. n = 5.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_8-C</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>qRT-PCR analysis of mRNA levels of Shp2, Skp2, Aurka, Dll1, and Hey1 in EYFP+ and EYFP&#8722;cells isolated by FACS from MLN4924;MMTV&#8208;Cre;Shp2fl/fl;EYFP&#8722;/fltumors. Error bars represent SEM (n = 5).</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_8-D</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>Kaplan-Meier analysis of tumor formation in control (blue, n = 8) and GS493&#8208;pretreated (red, n = 8) MLN4924;MMTV&#8208;Cre;Shp2fl/flmice. The bar indicates the duration of treatment.</text>
    </passage>
  </document>
  <document>
    <id>4474526 Figure_8-E</id>
    <infon key="sourcedata_document">2013</infon>
    <infon key="doi">10.15252/embj.201489004</infon>
    <infon key="pmc_id">4474526</infon>
    <infon key="figure">Figure 8-E</infon>
    <infon key="sourcedata_figure_dir">Figure_8-E</infon>
    <passage>
      <offset>0</offset>
      <text>Tumorgrowth curves for control (blue, n = 5) and GS493&#8208;treated (red, n = 5) MLN4924 mice. Note that after day 24, all mice in the control group were sacrificed due to the tumor size. Error bars represent SEM (n = 5).</text>
    </passage>
  </document>
</collection>
